Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole.
about
Pathogenesis of Helicobacter pylori infectionOpen-access upper gastrointestinal endoscopy a decade after the introduction of proton pump inhibitors and helicobacter pylori eradication: a shift in endoscopic findings.Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months.The effect of Helicobacter pylori infection and eradication in patients with gastro-oesophageal reflux disease: A parallel-group, double-blind, placebo-controlled multicentre study.Review article: the clinical influence of Helicobacter pylori in effective acid suppression-implications for the treatment of gastro-oesophageal reflux disease.Review article: is Helicobacter pylori status relevant in the management of GORD?Helicobacter pylori infection--current treatment practice.Review Article: is Helicobacter pylori relevant in the management of reflux disease?Gastroesophageal reflux and Helicobacter pylori: a review.Treatment of Helicobacter pylori.Review article: gastro-oesophageal reflux disease and Helicobacter pylori infection.Review article: an approach to Helicobacter pylori infection in the elderly.Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review.Pharmacotherapy for chronic gastro-oesophageal reflux disease and Barrett's oesophagus.Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully respondedPrognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trialRole of pantoprazole in the treatment of gastro-oesophageal reflux disease.The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients.Treatment of uncomplicated reflux diseaseConsequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.Proton pump inhibitors and Helicobacter pylori gastritis: friends or foes?The Proton Pump Inhibitor Non-Responder: A Clinical ConundrumComparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitisA review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD).A review of current guidelines for the management of Helicobacter pylori infection in children and adolescents.Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis.Esomeprazole: potent acid suppression in the treatment of acid-related disorders.The intriguing relationship of Helicobacter pylori infection and acid secretion in peptic ulcer disease and gastric cancer.Endoscopic grading of gastroesophageal flap valve helps predict proton pump inhibitor response in patients with gastroesophageal reflux disease.Helicobacter pylori-Induced Changes in Gastric Acid Secretion and Upper Gastrointestinal Disease.Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom ReseDoes Helicobacter pylori infection influence response rate or speed of symptom control in patients with gastroesophageal reflux disease treated with rabeprazole?Micromotor-enabled active drug delivery for in vivo treatment of stomach infection.Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis.Proton pump inhibitors and gastric neoplasia.Effect of Helicobacter pylori eradication on the treatment of gastro-oesophageal reflux disease.Helicobacter pylori eradication does not exacerbate gastro-oesophageal reflux disease.Helicobacter pylori infection and long term proton pump inhibitor therapy.
P2860
Q24679810-447B3BA5-4585-4CA0-83F1-13ED1390851AQ30483600-CE663DBD-921D-44E3-A39E-D721C9501825Q32026591-4994A113-438B-4F2D-8308-98CAF1115407Q33695532-CE023AD3-F50C-4892-A4BE-F61129138D8AQ33994156-7F63D187-DC42-4186-B50E-CA8B1B6335DAQ34069835-F9BCE5BA-D3E1-4E55-88E0-49E42F9A3020Q34240824-77F1F581-30A2-4B11-9D86-61B8B825D271Q34327956-946A9140-FA62-4401-B4CB-45CB8783C878Q34511969-E69794CC-B5C1-44A3-AE7B-FAC0929EA508Q34512048-4A899739-CE84-4F11-B067-AC5EE155B776Q34534346-BFDE5DE7-D54D-49F6-B343-D12E545C9730Q34585332-8E06807E-BC65-4926-8411-312841C2B9F4Q35099574-6BF7E118-442B-4F67-B99D-DA10270C919DQ35164691-A5A8C5B9-B2BF-419E-82AF-D9A69EC14681Q35587530-FD1342BF-FBF1-4DA3-B0AC-4D11930087B3Q35597478-1A626CDC-5F90-4391-AEC8-74DA0E6C9F95Q35598239-EE3FC581-AEB0-460A-A66C-5C42E4F44963Q36040702-83D5A371-BE2F-47FE-A61C-21A2E9CEE794Q36041651-AAA57482-2006-4655-A299-510CDEFA30CEQ36179053-D476F348-4095-44C3-B173-757BDCEEB39EQ36204260-29059376-537D-45E1-A0D1-7CAB3D560E67Q36376528-AC157E3D-FD3F-4B57-80EA-624F57660E12Q36575935-9967DBE2-6AA6-4BF9-A35F-42162213D353Q36752080-6C3204E5-606E-49B9-B603-42A46BEF01BEQ37122451-29AE8301-7FB0-4FB6-9DDD-1CC5DE310663Q37160360-3AC7FFED-C6F8-487A-B170-D0974AE79D8CQ37298163-C6B48FDF-32A9-4F14-B3E8-ED27723920A2Q37678186-EA0EB1C5-37F5-47CD-AC2D-211BDF639D40Q37755220-F8768BDA-EE3D-4BB0-BA71-C1F538B7A333Q37957698-B550F186-A1E4-42CE-930F-240FA67E6023Q38473878-CD8C6CE6-DF94-4800-A05B-6F7D40363697Q39104046-C9F43A27-3A8B-40F5-8DD9-F95E7757FAC4Q39260588-AFC2E2D1-CD7F-4A65-A313-3736FEE49B2AQ39345800-F0EEC469-3DEB-4875-AB87-27F1BA5DA091Q40090937-46EC1EC7-FA45-44EB-B986-8E9B2AE69C90Q41560226-EAD7202D-CEC2-47DD-934E-215111BFCEC9Q41818014-9E35293C-8363-450B-945E-3D33A86DB63EQ41831611-312F5D3F-381C-40DF-BFA2-4EF1399EF9BFQ41854429-3B8C547F-A44D-4FB9-9D6E-7283B13B5901Q42003652-A7AFBEAF-545D-4248-B6E5-9D6FD0FB01B3
P2860
Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Gastric Helicobacter pylori in ...... n pump inhibitor pantoprazole.
@en
Gastric Helicobacter pylori in ...... n pump inhibitor pantoprazole.
@nl
type
label
Gastric Helicobacter pylori in ...... n pump inhibitor pantoprazole.
@en
Gastric Helicobacter pylori in ...... n pump inhibitor pantoprazole.
@nl
prefLabel
Gastric Helicobacter pylori in ...... n pump inhibitor pantoprazole.
@en
Gastric Helicobacter pylori in ...... n pump inhibitor pantoprazole.
@nl
P1433
P1476
Gastric Helicobacter pylori in ...... n pump inhibitor pantoprazole.
@en
P2093
P Malfertheiner
P356
10.1016/S0016-5085(99)70544-5
P407
P577
1999-07-01T00:00:00Z